2016 International Congress Archives - Page 39 of 207

12:00pm-1:30pm: Proprioceptive training as a means to enhance sensorimotor function in Parkinson’s disease

N. Elangovan, P. Tuite, J. Konczak (Minneapolis, MN, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Pseudodystonic upper limb secondary to thalamic lesions: Usefulness of ultrasound-guided botulinum toxin treatment

C. Costa, P. Pita Lobo (Amadora, Portugal)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Psychiatric co-morbidity is highly prevalent in idiopathic cervical dystonia and significantly influences health-related quality of life: Results of a controlled study

M. Smit, A. Kuiper, V. Han, V.C.R. Jiawan, G. Douma, B. van Harten, J.M.T.H. Oen, M.E. Pouwels, H.J.G. Dieks, A.L. Bartels, M.A.J. Tijssen (Groningen, Netherlands)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Psychiatric disorders and personality traits in patients with functional dystonia

A. Tomic, M. Svetel, I. Petrovic, N. Dragasevic Miskovic, D. Pesic, M. Mitkovic, A. Potrebic, N. Kresojevic, V.S. Kostic (Belgrade, Serbia)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Psychogenic gait disorders in children – Report of 2 cases

S. Lorenzl, M. Kranz (Hausham, Germany)

Pediatric movement disorder · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Psychogenic non-epileptic seizures among patients with temporal lobe and other epilepsies: Phenomenology and EEG correlates

B.D. Wissel, A.K. Dwivedi, T.E. Gaston, F.J. Rodriguez-Porcel, D. Al Jaafari, J.L. Hopp, A. Krumholz, Y. Wang, S.M.A. van der Salm, D.M. Andrade, F. Borlot, B.D. Moseley, J.L. Cavitt, S. Williams, J. Stone, W.C. LaFrance Jr, J.P. Szaflarski, A.J. Espay (Cincinnati, OH, USA)

Other · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Quantitative measurements of deficit type and severity in focal embouchure dystonia

A.E. Morris, S.D. Anderson, J.W. Mink (Rochester, NY, USA)

Dystonia · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Randomised trial comparing dopamine agonist, MAOB inhibitor and COMT inhibitor as adjuvant therapy in later Parkinson’s disease (PD)

C.E. Clarke, S. Patel, N. Ives, C. Rick, A. Gray, C. Jenkinson, E. McIntosh, K. Wheatley, A. Williams, R. Gray (Birmingham, United Kingdom)

Parkinsons's Disease: Clinical Trials I

12:00pm-1:30pm: Randomized controlled trial protocol: Balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease

T.T.C. Capato, J. Tornai, V.F. Gianguiagi, R.R. Firmino, E.R. Barbosa, M.E. Piemonte (São Paulo, Brazil)

Clinical trials and therapy in movement disorders · Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm: Rasagiline treatment for sleep disorders in Parkinson’s disease (RaSPar) – Double-blinded, randomized, placebo-controlled, placebo run-in-phase, polysomnography clinical trial

W. Schrempf, M. Fauser, K. Otto, M. Wienecke, C. Ossig, S. Brown, A. Maass, M.D. Brandt, U. Schwanebeck, X. Graehlert, H. Reichmann, A. Storch (Dresden, Germany)

Parkinson's disease: Clinical trials, pharmacology and treatment · Exhibit Hall located in Hall B, Level 2